The response of embryonal carcinoma (EC) to the mouse blastocyst has been examined using a clonal assay for growth regulation. This in vitro assay is based on the ability of the blastocyst to abrogate colony formation by the cancer cell, and the results are similar to previous studies in which the blastocyst prevented tumor formation of EC cells. Other laboratories have shown that the environment of the early embryo forces some EC cells to participate in normal embryonic development. The current research is aimed at elucidating the role of cell-cell contact in this reaction and at determining whether the mechanism is based on metabolic cooperation via intercellular junctions or on plasma membrane interactions (i.e., recognition). The methods include cell cycle synchronization of EC, microsurgery to place EC cells in the blastocyst, rescue of cancer cells from the blastocyst by immunosurgery, microsurgery to create fistulas in blastocysts, isolation of cell types from the blastocyst, microculture techniques to prepare cytoplasmic and membrane preparation from blastocysts, electron microscopy of gap junctions, microinjection into cells, and electrophoretic and immunological studies of surface proteins. The possible role of metabolic cooperation will be studied by transfer of small molecules between cells and by use of variant cell lines incapable of metabolic cooperation. The possible role of cell surface recognition will be studied by testing isolated cells and membrane preparations of blastocysts for their growth regulatory activity in microculture. The goal is to understand the mechanisms which regulate normal stem cells in early embryogenesis and to apply these mechanisms to the regulation of malignant stem cells. The use of a tissue culture assay for growth regulation of EC provides a convenient probe of regulatory mechanisms in the blastocyst. Ultimately, the embryological approach might lead to alternatives to cytotoxic therapy for cancer. (A)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA036069-02
Application #
3173570
Study Section
Pathology B Study Section (PTHB)
Project Start
1983-12-01
Project End
1986-11-30
Budget Start
1984-12-01
Budget End
1985-11-30
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Parchment, R E; Gramzinski, R A; Pierce, G B (1990) Embryonic mechanisms for abrogating the malignancy of cancer cells. Prog Clin Biol Res 354A:331-44
Pierce, G B; Lewellyn, A L; Parchment, R E (1989) Mechanism of programmed cell death in the blastocyst. Proc Natl Acad Sci U S A 86:3654-8
Pierce, G B; Speers, W C (1988) Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res 48:1996-2004
Pierce, G B; Arechaga, J; Muro, C et al. (1988) Differentiation of ICM cells into trophectoderm. Am J Pathol 132:356-64
Pierce, G B; Arechaga, J; Jones, A et al. (1987) The fate of embryonal-carcinoma cells in mouse blastocysts. Differentiation 33:247-53
Pierce, G B; Arechaga, J; Wells, R S (1986) Embryonic control of cancer. Prog Clin Biol Res 226:67-77
Gerschenson, M; Graves, K; Carson, S D et al. (1986) Regulation of melanoma by the embryonic skin. Proc Natl Acad Sci U S A 83:7307-10